Innovation in Drug Discovery for Pharma and Biotech
This free half-day event will focus on accelerating drug development by harnessing new tools such as AI and cloud for competitive advantage.
The event is ideal for people in the Pharmaceutical, Biotech, and CRO industries and the NHS who want to innovate and transform drug development.
With the advent of AI and the continued expansion of cloud-based solutions, this event showcases how advanced cloud content management and AI technologies drive transformative change in CRO, biotech, and pharma R&D operations.
Discussions will center on seamless integration strategies, AI-driven resource optimization, and data-powered decision-making to maximize research productivity and market position.
This half-day event offers actionable insights for R&D executives and operations leaders seeking to leverage technology for strategic growth in the evolving life sciences landscape.
Agenda:
8.30 AM-9.30 AM - Registration and Breakfast
9.30 AM-10.00 AM - Opening Remarks
10.00 AM-11.00 AM - Panel Discussion
11.00 AM-11.15 AM - Closing Remarks
11.15 AM-Noon - Mix and Mingle
Noon - Meeting Ends
Speakers:
Dr. Helen Shaw
Co-Founder and Managing Director
VCTC
The VCTC is a UK-based patient-centric clinical trial site that eliminates the burden of participation and facilitates the rapid recruitment of patients.
The goal is to take clinical trials to patients, providing access to all, generating diversity and quality data through a compassionate, expedited virtual clinical trial process, enhancing the clinical trial experience for participants and sponsors leading to expedited timelines, reduced cost, and ultimately bringing products to market quicker.
Alison Holland
Chief Customer Officer
Medable, inc.
Medable provides an end-to-end, global cloud platform with a flexible suite of tools that allows sponsors, patients, providers & CRO's to work together as a team in clinical trials, enabling more efficient clinical research, more effective healthcare delivery, and more accurate precision and predictive medicine
Mike Rea
CEO
IDEA Pharma
IDEA Pharm is the industry leader in early-phase positioning and path-to-market strategy. The Pharmaceutical Innovation Index is the industry-standard ranking of innovation.
IDEA has positioned 8 of the 15 biggest drug launches of the past 3 years, and 25% of the 50 fastest-growing new medicines in the last 5 years - including Opdivo, the most successful oncology launch ever, and Ocrevus, which Roche claims as their best-ever launch.
Dr. Shikta Das
Real World Evidence Scientific Lead, Oncology
Astra Zeneca
Dr. Das is an accomplished Genetic Epidemiologist who has been serving as a Scientific Lead at AstraZeneca since 2021. Her expertise spans a wide spectrum of therapeutic areas, including Cardiovascular, Renal & Metabolism (CVRM), and Oncology. In her role, Shikta spearheads the analysis and reporting of diverse clinical and real-world database studies, employing advanced epidemiological methodologies. As an authority in epidemiology, she extends her statistical acumen and knowledge-mining capabilities to broader teams within AstraZeneca UK.
Dr. Das holds a Master's in Bioinformatics from Birkbeck College and a Ph.D. in Epidemiology from Imperial College London and has held various research positions at Imperial College and University College London.
Moderator:
Manu Vohra
Managing Director, Global Life Sciences
Box
Manu Vohra is the Global lead for Life Sciences and Go-To-Market strategy for Cloud Content Management at Box.